José F Carrillo1, Christian Cruz-Romero1, Alejandro Avilés-Salas2, Liliana C Carrillo3, Margarita C Ramírez-Ortega4, Roberto Herrera-Goepfert2, Rafael Vázquez-Romo1, Gabriela Figueroa-González5, Javier I Altamirano-García6, Luis F Oñate-Ocaña7. 1. Departamento de Cabeza y Cuello, Instituto Nacional de Cancerología, Mexico City, Mexico. 2. Departamento de Patología, Instituto Nacional de Cancerología, Mexico City, Mexico. 3. Subdirección de Investigación Clínica, Instituto Nacional de Cancerología, Mexico City, Mexico. 4. Subdirección de Investigación Básica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico. 5. Unidad de Investigación Multidisciplinaria (UMIEZ), Facultad de Estudios Superiores Zaragoza, UNAM, Mexico City, Mexico. 6. Subdirección de Radioterapia, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico. 7. Subdirección de Investigación Clínica, Instituto Nacional de Cancerología, Mexico City, Mexico. lfonate@gmail.com.
Abstract
BACKGROUND: The expression of liver kinase B1 (LKB-1) has been associated with prognosis in squamous cell carcinoma of the oral cavity (SCCOC). This study aimed to define the prognostic role of LKB-1 expression for patients with SCCOC and the suitability of its integration into a multivariate prognostic model. METHODS: A retrospective cohort study of patients with SCCOC was conducted in a cancer center. Expression of LKB-1 was evaluated by immunohistochemistry, and multivariate analysis defined prognostic factors associated with recurrence, recurrence-free survival (RFS), and overall survival (OS). The logistic regression model was used to construct a predictive computer software program. RESULTS: Of the 201 patients in this study, 104 (51.7%) experienced recurrence of their disease. Lower expression of LKB-1, high-risk histopathology, and advanced tumor-node-metastasis (TNM) stages were independent factors via multivariate analysis associated with the increased recurrence risk, poor RFS, and poor OS. If lack of LKB-1 expression is considered the reference category, the factors independently associated with recurrence were low (odds ratio [OR], 0.157; 95% confidence interval [CI], 0.044-0.557), intermediate (OR, 0.073; 95% CI, 0.017-0.319), and intense (OR, 0.047; 95% CI, 0.007-0.304) expression of LKB-1. This model permitted construction of a computer software program capable of prediction with receiver operating characteristic analysis (area under the curve, 0.925) and led to the definition of five prognostic groups with a biologic gradient. CONCLUSION: These results suggest that LKB-1 expression in patients with SCCOC is of robust prognostic value and complements the TNM staging system. The proposed model requires external validation in prospective observational studies.
BACKGROUND: The expression of liver kinase B1 (LKB-1) has been associated with prognosis in squamous cell carcinoma of the oral cavity (SCCOC). This study aimed to define the prognostic role of LKB-1 expression for patients with SCCOC and the suitability of its integration into a multivariate prognostic model. METHODS: A retrospective cohort study of patients with SCCOC was conducted in a cancer center. Expression of LKB-1 was evaluated by immunohistochemistry, and multivariate analysis defined prognostic factors associated with recurrence, recurrence-free survival (RFS), and overall survival (OS). The logistic regression model was used to construct a predictive computer software program. RESULTS: Of the 201 patients in this study, 104 (51.7%) experienced recurrence of their disease. Lower expression of LKB-1, high-risk histopathology, and advanced tumor-node-metastasis (TNM) stages were independent factors via multivariate analysis associated with the increased recurrence risk, poor RFS, and poor OS. If lack of LKB-1 expression is considered the reference category, the factors independently associated with recurrence were low (odds ratio [OR], 0.157; 95% confidence interval [CI], 0.044-0.557), intermediate (OR, 0.073; 95% CI, 0.017-0.319), and intense (OR, 0.047; 95% CI, 0.007-0.304) expression of LKB-1. This model permitted construction of a computer software program capable of prediction with receiver operating characteristic analysis (area under the curve, 0.925) and led to the definition of five prognostic groups with a biologic gradient. CONCLUSION: These results suggest that LKB-1 expression in patients with SCCOC is of robust prognostic value and complements the TNM staging system. The proposed model requires external validation in prospective observational studies.
Authors: Andrew P Stein; Sandeep Saha; Jennifer L Kraninger; Adam D Swick; Menggang Yu; Paul F Lambert; Randall J Kimple Journal: Cancer J Date: 2015 May-Jun Impact factor: 3.360
Authors: Alhadi Almangush; Antti A Mäkitie; Asterios Triantafyllou; Remco de Bree; Primož Strojan; Alessandra Rinaldo; Juan C Hernandez-Prera; Carlos Suárez; Luiz P Kowalski; Alfio Ferlito; Ilmo Leivo Journal: Oral Oncol Date: 2020-05-20 Impact factor: 5.337
Authors: Margaret Brandwein-Gensler; Miriam S Teixeira; Carol Ming Lewis; Bryant Lee; Linda Rolnitzky; Johannes J Hille; Eric Genden; Mark L Urken; Beverly Yiyao Wang Journal: Am J Surg Pathol Date: 2005-02 Impact factor: 6.394
Authors: Yufeng Li; Shuting Bai; William Carroll; Dan Dayan; Joseph C Dort; Keith Heller; George Jour; Harold Lau; Carla Penner; Michael Prystowsky; Eben Rosenthal; Nicolas F Schlecht; Richard V Smith; Mark Urken; Marilena Vered; Beverly Wang; Bruce Wenig; Abdissa Negassa; Margaret Brandwein-Gensler Journal: Head Neck Pathol Date: 2012-12-19
Authors: Daniel E Johnson; Barbara Burtness; C René Leemans; Vivian Wai Yan Lui; Julie E Bauman; Jennifer R Grandis Journal: Nat Rev Dis Primers Date: 2020-11-26 Impact factor: 52.329